Comparison of cytokine responses with anti-d and intravenous immunoglobulin in idiopathic thrombocytopenia.
作者信息
Khan Sujoy
机构信息
Department of Allergy & Immunology, Apollo Gleneagles Hospital, Kolkata, West Bengal, India.
出版信息
Transfus Med Hemother. 2013 Feb;40(1):49. doi: 10.1159/000345740. Epub 2013 Jan 3.
Abstract
摘要
相似文献
1
Comparison of cytokine responses with anti-d and intravenous immunoglobulin in idiopathic thrombocytopenia.
Transfus Med Hemother. 2013 Feb;40(1):49. doi: 10.1159/000345740. Epub 2013 Jan 3.
2
Intravenous Immunoglobulin Versus Anti-D Immunoglobulin: When Better Treatment May Not Be the Best Treatment.
J Pediatr. 2019 Jan;204:11-13. doi: 10.1016/j.jpeds.2018.08.062. Epub 2018 Sep 28.
3
Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
Acta Haematol. 2006;115(1-2):46-52. doi: 10.1159/000089465.
4
Intravenous immunoglobulin and anti-RhD therapy in the management of immune thrombocytopenia.
Hematol Oncol Clin North Am. 2009 Dec;23(6):1317-27. doi: 10.1016/j.hoc.2009.09.002.
5
A serious thrombotic event in a patient with immune thrombocytopenia requiring intravenous immunoglobulin: a case report.
J Med Case Rep. 2019 Jan 28;13(1):25. doi: 10.1186/s13256-018-1955-x.
6
The treatment of chronic idiopathic thrombocytopenia with anti-D (Rho) immunoglobulin: its effectiveness, safety and mechanism of action.
Clin Lab Haematol. 1988;10(3):275-84. doi: 10.1111/j.1365-2257.1988.tb00021.x.
7
Two types of autoantibody-mediated thrombocytopenia in patients with systemic lupus erythematosus.
Rheumatology (Oxford). 2006 Jul;45(7):851-4. doi: 10.1093/rheumatology/kel010. Epub 2006 Jan 17.
8
Idiopathic thrombocytopenia purpura: Treatment patterns and an analysis of cost associated with intravenous immunoglobulin and anti-D therapy.
Semin Hematol. 1998 Jan;35(1 Suppl 1):58-64.
9
The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: what do we really know?
Transfus Med Rev. 2008 Apr;22(2):103-16. doi: 10.1016/j.tmrv.2007.12.001.
10
Antiplatelet antibody testing in thrombocytopenic pregnant women.
Am J Obstet Gynecol. 1996 Mar;174(3):1014-8. doi: 10.1016/s0002-9378(96)70342-3.
本文引用的文献
1
Influence of Intravenous Immunoglobulin Treatment on Thrombopoiesis.
Transfus Med Hemother. 2012 Jun;39(3):217-220. doi: 10.1159/000339258. Epub 2012 May 15.
2
Clinical significance of serum cytokine levels and thrombopoietic markers in childhood idiopathic thrombocytopenic purpura.
Blood Transfus. 2012 Apr;10(2):194-9. doi: 10.2450/2011.0055-11. Epub 2011 Nov 15.
3
Rozrolimupab, symphobodies against rhesus D, for the potential prevention of hemolytic disease of the newborn and the treatment of idiopathic thrombocytopenic purpura.
Curr Opin Mol Ther. 2010 Dec;12(6):734-40.
4
Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti-D by FcgammaRIIa and FcgammaRIIIa polymorphisms.
Br J Haematol. 2004 Feb;124(4):511-8. doi: 10.1111/j.1365-2141.2004.04804.x.
5
Release of cytokines and soluble cytokine receptors after intravenous anti-D treatment in children with chronic thrombocytopenic purpura.
Hematol J. 2001;2(4):242-9. doi: 10.1038/sj.thj.6200106.
Zotero 插件